首页> 外文期刊>Journal of medical Internet research >Designing a Distributed Ledger Technology System for Interoperable and General Data Protection Regulation–Compliant Health Data Exchange: A Use Case in Blood Glucose Data
【24h】

Designing a Distributed Ledger Technology System for Interoperable and General Data Protection Regulation–Compliant Health Data Exchange: A Use Case in Blood Glucose Data

机译:设计用于可互操作和通用数据保护法规的分布式分类帐技术系统-符合标准的健康数据交换:血糖数据中的用例

获取原文
           

摘要

Background Distributed ledger technology (DLT) holds great potential to improve health information exchange. However, the immutable and transparent character of this technology may conflict with data privacy regulations and data processing best practices. Objective The aim of this paper is to develop a proof-of-concept system for immutable, interoperable, and General Data Protection Regulation (GDPR)–compliant exchange of blood glucose data. Methods Given that there is no ideal design for a DLT-based patient-provider data exchange solution, we proposed two different variations for our proof-of-concept system. One design was based purely on the public IOTA distributed ledger (a directed acyclic graph-based DLT) and the second used the same public IOTA ledger in combination with a private InterPlanetary File System (IPFS) cluster. Both designs were assessed according to (1) data reversal risk, (2) data linkability risks, (3) processing time, (4) file size compatibility, and (5) overall system complexity. Results The public IOTA design slightly increased the risk of personal data linkability, had an overall low processing time (requiring mean 6.1, SD 1.9 seconds to upload one blood glucose data sample into the DLT), and was relatively simple to implement. The combination of the public IOTA with a private IPFS cluster minimized both reversal and linkability risks, allowed for the exchange of large files (3 months of blood glucose data were uploaded into the DLT in mean 38.1, SD 13.4 seconds), but involved a relatively higher setup complexity. Conclusions For the specific use case of blood glucose explored in this study, both designs presented a suitable performance in enabling the interoperable exchange of data between patients and providers. Additionally, both systems were designed considering the latest guidelines on personal data processing, thereby maximizing the alignment with recent GDPR requirements. For future works, these results suggest that the conflict between DLT and data privacy regulations can be addressed if careful considerations are made regarding the use case and the design of the data exchange system.
机译:背景技术分布式账本技术(DLT)在改善健康信息交换方面具有巨大潜力。但是,该技术的不变性和透明性可能与数据隐私法规和数据处理最佳实践相冲突。目的本文的目的是开发一种概念证明系统,用于不可变,可互操作且符合通用数据保护法规(GDPR)的血糖数据交换。方法鉴于没有理想的基于DLT的患者提供者数据交换解决方案的设计,我们为概念验证系统提出了两种不同的变体。一种设计纯粹基于公共IOTA分布式分类帐(基于有向无环图的DLT),第二种设计使用同一公共IOTA分类帐与私有行星间文件系统(IPFS)群集结合使用。两种设计均根据(1)数据反转风险,(2)数据链接风险,(3)处理时间,(4)文件大小兼容性和(5)总体系统复杂性进行了评估。结果公开的IOTA设计稍微增加了个人数据可链接性的风险,总的处理时间很短(将一个血糖数据样本上传到DLT所需的平均时间为6.1,SD为1.9秒),并且实现起来相对简单。公共IOTA与私有IPFS集群的组合使反向和链接风险最小化,允许交换大文件(3个月的血糖数据平均以38.1,SD的13.4秒上传到DLT中),但是相对而言更高的设置复杂度。结论对于本研究中探讨的特定血糖使用案例,两种设计均表现出合适的性能,能够在患者和提供者之间互操作数据交换。此外,两种系统的设计均考虑了有关个人数据处理的最新准则,从而最大限度地满足了最新的GDPR要求。对于将来的工作,这些结果表明,如果仔细考虑用例和数据交换系统的设计,则可以解决DLT与数据隐私法规之间的冲突。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号